Dr. Dewani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
810 Jasonway Ave
Ste A
Columbus, OH 43214Phone+1 614-442-3130Fax+1 614-442-3145
Education & Training
- Wright State UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
- Wright State UniversityResidency, Internal Medicine, 2006 - 2009
- Padmashree Dr. D.Y. Patil Medical CollegeClass of 2005
Certifications & Licensure
- OH State Medical License 2006 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha
Publications & Presentations
PubMed
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15 - 1 citationsReply to T. Shimoi et al and Y. Shimanuki et al.Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-09-23 - 78 citationsRandomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuva...Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-06-06
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: